ProCE Banner Activity

Essential Testing in Early Breast Cancer: A Focus on BRCA Testing and Adjuvant PARP Inhibition

PDF
Review and share this quick guide with key insights on how to identify patients with breast cancer who may benefit from treatment with adjuvant olaparib.

Released: November 14, 2022

Expiration: November 13, 2023

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

ProCE

ProCE Banner